Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes [Phase 3]
This Phase 3 trial evaluated the efficacy and safety of adding vildagliptin to metformin in adults with Type 2 diabetes mellitus. The study …
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Vildagliptin 100 mg Once Daily vs. Placebo as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin [Phase 3]
A Phase 3 trial evaluating vildagliptin 100 mg once daily as add-on therapy to metformin versus placebo in adults with type 2 diabetes inade…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications [Phase 4]
A Phase 4 trial comparing vildagliptin and liraglutide assessed patient treatment preference after receiving both drugs in adults with Type …
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects [Phase 1]
Phase 1 study by Novo Nordisk evaluated optimal dosing for a long-acting GLP-1 receptor agonist in healthy male volunteers; the trial status…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin [Phase 4]
This update covers a Phase 4 trial of vildagliptin 50 mg twice daily in patients with type 2 diabetes mellitus inadequately controlled with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes [Phase 3]
This document reports the completion of a Phase 3 clinical trial evaluating the long-term safety and efficacy of Biphasic Insulin Aspart 30 …
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes [Phase 3]
A phase 3 clinical trial evaluating the safety and efficacy of Biphasic Insulin Aspart 50 in adults with Type 2 diabetes has completed, with…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Biphasic Insulin Aspart 30 in adults with type 1 or type 2 diabetes; the study has been …
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 long-term safety and efficacy results for Biphasic Insulin Aspart 30 in adults with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes. [Phase 4]
A Phase 4 trial comparing insulin glargine to biphasic insulin aspart 30/70, each in combination with metformin, in adults with type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes [Phase 4]
Phase 4 clinical trial update assessing the efficacy and safety of NovoMix 30 in subjects with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes [Phase 4]
This Phase 4 trial evaluated the efficacy and safety of combining metformin with biphasic insulin aspart 30 in adults with type 2 diabetes. …
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese Subjects [Phase 1]
Phase 1 study completed evaluating bioequivalence of two formulations of Biphasic Insulin Aspart 50 in healthy Japanese subjects.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs [Phase 4]
Phase 4 clinical trial evaluating the efficacy of Biphasic Insulin Aspart 30 in patients with Type 2 diabetes mellitus inadequately controll…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes [Phase 1]
A Phase 1 study evaluating the diabetes drug candidate NNC 55-0414 in adults with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes [Phase 4]
A Phase 4 completed trial evaluating the efficacy and safety of Biphasic Insulin Aspart 30 FlexPen in adults with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone [Phase 4]
Phase 4 trial assessing the safety and efficacy of nateglinide in people with type 2 diabetes already taking insulin glargine and/or metform…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial updating on glycemic control with biphasic insulin aspart 30 in patients with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands
This clinical trial update reports a switch from premixed human insulin to biphasic insulin aspart in patients with Type 2 diabetes in the N…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Initiation of Insulin Aspart in Type 2 Diabetes [Phase 4]
Phase 4 trial investigating insulin aspart for type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Add-on to Thiazolidinedione (TZD) Failures [Phase 3]
Phase 3 trial evaluating an add-on therapy to thiazolidinediones in Type 2 diabetes mellitus has completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus Glimepiride [Phase 3]
Phase 3 trial evaluating Galvus (vildagliptin) as add-on to metformin and glimepiride in type 2 diabetes; safety and efficacy results report…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets [Phase 3]
Phase 3 trial update for BMS-512148 in combination with metformin for type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Continuous Multiple Dose PB-119 Injection in Health Volunteers [Phase 1]
Phase 1 trial evaluating continuous multiple-dose PB-119 injection in healthy volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of adding vildagliptin to insulin in adults with type 2 diabetes mellitus has co…